Literature DB >> 24131384

A non-coding mutation in the 5' untranslated region of patched homologue 1 predisposes to basal cell carcinoma.

Julia K Tietze1, Martina Pfob, Marlene Eggert, Anna von Preußen, Yasmin Mehraein, Thomas Ruzicka, Thomas Herzinger.   

Abstract

Mutations in the human homolog of the Drosophila patched gene, patched homologue 1 (PTCH-1), are responsible for most hereditary and sporadic basal cell carcinomas. Here, we present a father and daughter with a high propensity for the development of basal cell carcinoma who were heterozygous for a non-coding germline mutation in the 5' untranslated region (UTR) of PTCH-1 (insertion of a surplus CGG triplet at the site of a seven times CGG repeat). We analysed the impact of this mutation on PTCH translation using a luciferase-based reporter vector. Insertion of an eighth CGG in the 5' UTR repressed protein translation dramatically when compared to the wild-type sequence. Our results suggest that this non-coding variant in the 5' UTR represents a mutation predisposing to basal cell carcinoma.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  5’ untranslated region; basalcellcarcinoma; patched homologue 1-mutation

Mesh:

Substances:

Year:  2013        PMID: 24131384     DOI: 10.1111/exd.12267

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  2 in total

1.  Regulation of human PTCH1b expression by different 5' untranslated region cis-regulatory elements.

Authors:  Petar Ozretić; Alessandra Bisio; Vesna Musani; Diana Trnski; Maja Sabol; Sonja Levanat; Alberto Inga
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

2.  Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.

Authors:  Giuseppina Della Vittoria Scarpati; Francesco Perri; Salvatore Pisconti; Giuseppe Costa; Filippo Ricciardiello; Salvatore Del Prete; Alberto Napolitano; Marco Carraturo; Salvatore Mazzone; Raffaele Addeo
Journal:  Mol Clin Oncol       Date:  2016-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.